BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
BIOTRICITY INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026
- Market cap
- $1.15M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.2%
0M of 20M shares
Institutional holders
1
0 new, 1 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ionic Ventures, LLC | 3,241,770 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BTCY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Strengthening Families & Communities, LLC | 48,263 | 0.24% | $5.99K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.2% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q1 2026 | 2 | 0M | 0.3% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.1% | 1 / 0 | 0 / 1 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.2% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q4 2024 | 0 | 0M | 0.0% | 0 / 0 | 0 / 4 | 0M | 0M |
| Q3 2024 | 4 | 0M | 0.3% | 1 / 0 | 0 / 16 | 0M | 0M |
| Q2 2024 | 20 | 0M | 2.4% | 6 / 3 | 3 / 2 | 0M | 0M |
| Q1 2024 | 16 | 0M | 1.8% | 1 / 2 | 3 / 5 | 0M | 0M |
| Q4 2023 | 20 | 0M | 1.8% | 3 / 3 | 5 / 4 | 0M | 0M |
| Q3 2023 | 21 | 1M | 2.5% | 21 / 0 | 0 / 0 | 1M | 0M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Norman M. Betts Director | Nov 29, 2021 | Award | +54,348 | – | – | 375,598 |
| David A. Rosa Director | Nov 29, 2021 | Award | +27,174 | – | – | 152,174 |
| David A. Rosa Director | Oct 11, 2021 | Sale | −3,318 | $3.05 | $10.12K | 125,000 |
| David A. Rosa Director | Oct 8, 2021 | Sale | −9,481 | $3.20 | $30.34K | 128,318 |
| David A. Rosa Director | Oct 7, 2021 | Sale | −17,228 | $3.08 | $53.06K | 137,799 |
| David A. Rosa Director | Sep 16, 2021 | Sale | −34,977 | $3.43 | $119.97K | 155,027 |
| David A. Rosa Director | Sep 15, 2021 | Sale | −6,246 | $3.27 | $20.42K | 190,004 |
| Patricia J. Kennedy Director | Apr 7, 2020 | Award | +125,000 | – | – | 250,000 |
| Norman M. Betts Director | Apr 7, 2020 | Award | +125,000 | – | – | 321,250 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.